Discharge 2012: European Medicines Agency

This procedure concerns the 'discharge' of the European Medicines Agency's 2012 budget. This is a formal process where the European Parliament reviews how the agency spent its funds to ensure the money was used legally, efficiently, and for its intended purposes.

This affects the European Medicines Agency's administration and financial management. A positive discharge confirms that the agency's accounts are accurate and its spending is approved.